Metal nanoparticles and sensitivity/resistance to therapy in cancer: two sides of the coin?
Bibliographic record
Abstract
No abstract is available for this record. The assistant can identify its topic from the title, but cannot infer the study’s results.
Source: Not provided · Quality: missing
Research context
OpenAlex topics: Nanoparticle-Based Drug Delivery · Nanoplatforms for cancer theranostics · Nanoparticles: synthesis and applications
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (100+)
Show source-provided references
1. Tuna S, Beyler-Cigil A, Demir S (2022) Preparation and characterization of hybrid nanomaterials containing magnetic Fe3O4 nanoparticles as drug delivery system. Cell Chem Technol (7–8)
2. Sangour MH, Talib RA, Al AAALA, Atwan ZW (2022) Comparison the effects of Cds-Au nanoparticles on viability of normal and cancer cell lines and expression of P53 genes. J Pharmaceut Negative Results. 13(4):492–9
3. Kelley KD, Aronowitz P (2022) Cancer. Med Clin North Am 106(3):411–42210.1016/j.mcna.2021.12.006 ↗
4. Khaliq NU, Lee J, Kim J, Kim Y, Yu S, Kim J et al (2023) Mesoporous silica nanoparticles as a gene delivery platform for cancer therapy. Pharmaceutics 15(5):143210.3390/pharmaceutics15051432 ↗
5. Sancho-Albero M, Martín-Pardillos A, Lujan L, Sebastian V, Santamaria J, Martín-Duque P (2022) Exosomes loaded with ultrasmall Pt nanoparticles: a novel low-toxicity alternative to cisplatin. J Nanobiotechnol 20(1):1–1410.1186/s12951-022-01675-4 ↗
6. Mafi A, Rezaee M, Hedayati N, Hogan SD, Reiter RJ, Aarabi M-H et al (2023) Melatonin and 5-fluorouracil combination chemotherapy: opportunities and efficacy in cancer therapy. Cell Commun Signal 21(1):3310.1186/s12964-023-01047-x ↗
7. Greaves M, Maley CC (2012) Clonal evolution in cancer. Nature 481(7381):306–31310.1038/nature10762 ↗
8. Sharom FJ (2008) ABC multidrug transporters: structure, function and role in chemoresistance10.2217/14622416.9.1.105 ↗
9. Easwaran H, Tsai H-C, Baylin SB (2014) Cancer epigenetics: tumor heterogeneity, plasticity of stem-like states, and drug resistance. Mol Cell 54(5):716–72710.1016/j.molcel.2014.05.015 ↗
10. Abdullah LN, Chow EK-H (2013) Mechanisms of chemoresistance in cancer stem cells. Clin Translation Med 2:1–910.1186/2001-1326-2-3 ↗
11. Hanahan D, Coussens LM (2012) Accessories to the crime: functions of cells recruited to the tumor microenvironment. Cancer Cell 21(3):309–32210.1016/j.ccr.2012.02.022 ↗
12. Taylor S, Spugnini EP, Assaraf YG, Azzarito T, Rauch C, Fais S (2015) Microenvironment acidity as a major determinant of tumor chemoresistance: proton pump inhibitors (PPIs) as a novel therapeutic approach. Drug Resist Updates 23:69–7810.1016/j.drup.2015.08.004 ↗
13. Butler EB, Zhao Y, Muñoz-Pinedo C, Lu J, Tan M (2013) Stalling the engine of resistance: targeting cancer metabolism to overcome therapeutic resistance. Can Res 73(9):2709–271710.1158/0008-5472.CAN-12-3009 ↗
14. Sui X, Chen R, Wang Z, Huang Z, Kong N, Zhang M et al. (2013) Autophagy and chemotherapy resistance: a promising therapeutic target for cancer treatment. Cell Death Disease 4(10):e838-e10.1038/cddis.2013.350 ↗
15. Bhattacharya R, Mukherjee P (2008) Biological properties of “naked” metal nanoparticles. Adv Drug Deliv Rev 60(11):1289–130610.1016/j.addr.2008.03.013 ↗
16. Narayanan R, El-Sayed MA (2004) Shape-dependent catalytic activity of platinum nanoparticles in colloidal solution. Nano Lett 4(7):1343–134810.1021/nl0495256 ↗
17. Moura D, Souza M, Liverani L, Rella G, Luz G, Mano J et al (2017) Development of a bioactive glass-polymer composite for wound healing applications. Mater Sci Eng, C 76:224–23210.1016/j.msec.2017.03.037 ↗
18. Banerjee K, Das S, Choudhury P, Ghosh S, Baral R, Choudhuri SK (2017) A novel approach of synthesizing and evaluating the anticancer potential of silver oxide nanoparticles in vitro. Chemotherapy 62(5):279–28910.1159/000453446 ↗
19. Gomez-Romero P (2001) Hybrid organic–inorganic materials—in search of synergic activity. Adv Mater 13(3):163–17410.1002/1521-4095(200102)13:3<163::AID-ADMA163>3.0.CO;2-U ↗
20. Shaikh SF, Mane RS, Min BK, Hwang YJ, Joo O-s (2016) D-sorbitol-induced phase control of TiO2 nanoparticles and its application for dye-sensitized solar cells. Sci Reports 6(1):20103
21. Gracias DH, Tien J, Breen TL, Hsu C, Whitesides GM (2000) Forming electrical networks in three dimensions by self-assembly. Science. 289(5482):1170–210.1126/science.289.5482.1170 ↗
22. Xin Y, Yin M, Zhao L, Meng F, Luo L (2017) Recent progress on nanoparticle-based drug delivery systems for cancer therapy. Cancer Biol Med 14(3):22810.20892/j.issn.2095-3941.2017.0052 ↗
23. Yao Y, Zhou Y, Liu L, Xu Y, Chen Q, Wang Y et al (2020) Nanoparticle-based drug delivery in cancer therapy and its role in overcoming drug resistance. Front Mol Biosci 7:19310.3389/fmolb.2020.00193 ↗
24. Yang S, Gao H (2017) Nanoparticles for modulating tumor microenvironment to improve drug delivery and tumor therapy. Pharmacol Res 126:97–10810.1016/j.phrs.2017.05.004 ↗
25. Chen B, Dai W, He B, Zhang H, Wang X, Wang Y et al (2017) Current multistage drug delivery systems based on the tumor microenvironment. Theranostics 7(3):53810.7150/thno.16684 ↗
26. Sharma A, Goyal AK, Rath G (2018) Recent advances in metal nanoparticles in cancer therapy. J Drug Target 26(8):617–63210.1080/1061186X.2017.1400553 ↗
27. Păduraru DN, Ion D, Niculescu A-G, Mușat F, Andronic O, Grumezescu AM et al (2022) Recent developments in metallic nanomaterials for cancer therapy, diagnosing and imaging applications. Pharmaceutics 14(2):43510.3390/pharmaceutics14020435 ↗
28. Selvan ST, Tan TTY, Yi DK, Jana NR (2010) Functional and multifunctional nanoparticles for bioimaging and biosensing. Langmuir 26(14):11631–1164110.1021/la903512m ↗
29. Baptista P, Pereira E, Eaton P, Doria G, Miranda A, Gomes I et al (2008) Gold nanoparticles for the development of clinical diagnosis methods. Anal Bioanal Chem 391:943–95010.1007/s00216-007-1768-z ↗
30. Huang X, Jain PK, El-Sayed IH, El-Sayed MA (2007) Gold nanoparticles: interesting optical properties and recent applications in cancer diagnostics and therapy10.2217/17435889.2.5.681 ↗
31. Nishiyama N (2007) Nanomedicine: nanocarriers shape up for long life. Nat Nanotechnol 2(4):20310.1038/nnano.2007.88 ↗
32. Jones MR, Millstone JE, Giljohann DA, Seferos DS, Young KL, Mirkin CA (2009) Plasmonically controlled nucleic acid dehybridization with gold nanoprisms. ChemPhysChem 10(9–10):1461–146510.1002/cphc.200900269 ↗
33. Sau TK, Rogach AL, Jäckel F, Klar TA, Feldmann J (2010) Properties and applications of colloidal nonspherical noble metal nanoparticles. Adv Mater 22(16):1805–182510.1002/adma.200902557 ↗
34. Sperling RA, Gil PR, Zhang F, Zanella M, Parak WJ (2008) Biological applications of gold nanoparticles. Chem Soc Rev 37(9):1896–190810.1039/b712170a ↗
35. Xie J, Lee S, Chen X (2010) Nanoparticle-based theranostic agents. Adv Drug Deliv Rev 62(11):1064–107910.1016/j.addr.2010.07.009 ↗
36. Sperling RA, Parak WJ (1915) Surface modification, functionalization and bioconjugation of colloidal inorganic nanoparticles. Philos Trans Royal Soc A: Math Phys Eng Sci 2010(368):1333–1383
37. Jain PK, Huang X, El-Sayed IH, El-Sayed MA (2008) Noble metals on the nanoscale: optical and photothermal properties and some applications in imaging, sensing, biology, and medicine. Acc Chem Res 41(12):1578–158610.1021/ar7002804 ↗
38. Lee K-S, El-Sayed MA (2006) Gold and silver nanoparticles in sensing and imaging: sensitivity of plasmon response to size, shape, and metal composition. J Phys Chem B 110(39):19220–1922510.1021/jp062536y ↗
39. Chen H, Shao L, Ming T, Sun Z, Zhao C, Yang B et al (2010) Understanding the photothermal conversion efficiency of gold nanocrystals. Small. 6(20):2272–8010.1002/smll.201001109 ↗
40. Day ES, Morton JG, West JL (2009) Nanoparticles for thermal cancer therapy10.1115/1.3156800 ↗
41. Benko A, Medina-Cruz D, Vernet-Crua A, O’Connell CP, Świętek M, Barabadi H et al (2021) Nanocarrier drug resistant tumor interactions: novel approaches to fight drug resistance in cancer. Cancer Drug Resistance 4(2):264
42. Bhattacharyya S, Kudgus RA, Bhattacharya R, Mukherjee P (2011) Inorganic nanoparticles in cancer therapy. Pharm Res 28(2):237–25910.1007/s11095-010-0318-0 ↗
43. Shariatzadeh S, Moghimi N, Khalafi F, Shafiee S, Mehrabi M, Ilkhani S et al (2022) Metallic nanoparticles for the modulation of tumor microenvironment; a new horizon. Front Bioeng Biotechnol 10:84743310.3389/fbioe.2022.847433 ↗
44. Gil PR, Parak WJ (2008) Composite nanoparticles take aim at cancer. ACS Nano 2(11):2200–220510.1021/nn800716j ↗
45. Minelli C, Lowe SB, Stevens MM (2010) Engineering nanocomposite materials for cancer therapy. Small 6(21):2336–235710.1002/smll.201000523 ↗
46. Dinarvand R, Cesar de Morais P, D’Emanuele A (2012) Nanoparticles for targeted delivery of active agents against tumor cells. J Drug Del 201210.1155/2012/528123 ↗
47. Bernardi RJ, Lowery AR, Thompson PA, Blaney SM, West JL (2008) Immunonanoshells for targeted photothermal ablation in medulloblastoma and glioma: an in vitro evaluation using human cell lines. J Neurooncol 86:165–17210.1007/s11060-007-9467-3 ↗
48. Fichou Y, Férec C (2006) The potential of oligonucleotides for therapeutic applications. Trends Biotechnol 24(12):563–57010.1016/j.tibtech.2006.10.003 ↗
49. Mahmoudi M, Simchi A, Imani M, Milani AS, Stroeve P (2009) An in vitro study of bare and poly (ethylene glycol)-co-fumarate-coated superparamagnetic iron oxide nanoparticles: a new toxicity identification procedure. Nanotechnology 20(22):22510410.1088/0957-4484/20/22/225104 ↗
50. Arias LS, Pessan JP, Vieira APM, Lima TMTd, Delbem ACB, Monteiro DR (2018) Iron oxide nanoparticles for biomedical applications: a perspective on synthesis, drugs, antimicrobial activity, and toxicity. Antibiotics. 7(2):4610.3390/antibiotics7020046 ↗
51. Anderson SD, Gwenin VV, Gwenin CD (2019) Magnetic functionalized nanoparticles for biomedical, drug delivery and imaging applications. Nanoscale Res Lett 14(1):1–1610.1186/s11671-019-3019-6 ↗
52. Surface Modification of Nanoparticles for Targeted Drug Delivery 2019.
53. Zhu N, Ji H, Yu P, Niu J, Farooq M, Akram MW et al (2018) Surface modification of magnetic iron oxide nanoparticles. Nanomaterials 8(10):81010.3390/nano8100810 ↗
54. Matsumura Y, Maeda H (1986) A new concept for macromolecular therapeutics in cancer chemotherapy: mechanism of tumoritropic accumulation of proteins and the antitumor agent smancs. Cancer Res 46(12_Part_1):6387–92
55. Kunjachan S, Pola R, Gremse F, Theek B, Ehling J, Moeckel D et al (2014) Passive versus active tumor targeting using RGD-and NGR-modified polymeric nanomedicines. Nano Lett 14(2):972–98110.1021/nl404391r ↗
56. Maeda H (2015) Toward a full understanding of the EPR effect in primary and metastatic tumors as well as issues related to its heterogeneity. Adv Drug Deliv Rev 91:3–610.1016/j.addr.2015.01.002 ↗
57. Maeda H, Wu J, Sawa T, Matsumura Y, Hori K (2000) Tumor vascular permeability and the EPR effect in macromolecular therapeutics: a review. J Control Release 65(1–2):271–28410.1016/S0168-3659(99)00248-5 ↗
58. Caro C, Pozo D (2015) Polysaccharide colloids as smart vehicles in cancer therapy. Curr Pharm Des 21(33):4822–483610.2174/1381612821666150820100812 ↗
59. Lugano R, Ramachandran M, Dimberg A (2020) Tumor angiogenesis: causes, consequences, challenges and opportunities. Cell Mol Life Sci 77:1745–177010.1007/s00018-019-03351-7 ↗
60. Cabral H, Matsumoto Y, Mizuno K, Chen Q, Murakami M, Kimura M. Y. 34 Terada, MR Kano, K. Miyazono, M. Uesaka, N. Nishiyama, K. Kataoka (2011) 35 Accumulation of sub-100 nm polymeric micelles in poorly permeable tumours 36 depends on size. Nat Nanotechnol 6:815–2310.1038/nnano.2011.166 ↗
61. Kang H, Rho S, Stiles WR, Hu S, Baek Y, Hwang DW et al (2020) Size-dependent EPR effect of polymeric nanoparticles on tumor targeting. Adv Healthcare Mater 9(1):190122310.1002/adhm.201901223 ↗
62. Kalyane D, Raval N, Maheshwari R, Tambe V, Kalia K, Tekade RK (2019) Employment of enhanced permeability and retention effect (EPR): nanoparticle-based precision tools for targeting of therapeutic and diagnostic agent in cancer. Mater Sci Eng, C 98:1252–127610.1016/j.msec.2019.01.066 ↗
63. Longmire M, Choyke PL, Kobayashi H (2008) Clearance properties of nano-sized particles and molecules as imaging agents: considerations and caveats10.2217/17435889.3.5.703 ↗
64. Akhter MH, Beg S, Tarique M, Malik A, Afaq S, Choudhry H et al. (2021) Receptor-based targeting of engineered nanocarrier against solid tumors: recent progress and challenges ahead. Biochimica et Biophysica Acta (BBA) - General Subjects 1865(2):12977710.1016/j.bbagen.2020.129777 ↗
65. Ahmad J, Ahmad MZ, Akhter H (2020) Surface-engineered cancer nanomedicine: rational design and recent progress. Curr Pharm Des 26(11):1181–119010.2174/1381612826666200214110645 ↗
66. Muhamad N, Plengsuriyakarn T, Na-Bangchang K (2018) Application of active targeting nanoparticle delivery system for chemotherapeutic drugs and traditional/herbal medicines in cancer therapy: a systematic review. Int J Nanomed 13:392110.2147/IJN.S165210 ↗
67. Yang X, Wang Y, Huang X, Ma Y, Huang Y, Yang R et al (2011) Multi-functionalized graphene oxide based anticancer drug-carrier with dual-targeting function and pH-sensitivity. J Mater Chem 21(10):3448–345410.1039/C0JM02494E ↗
68. Akhter MH, Rizwanullah M, Ahmad J, Ahsan MJ, Mujtaba MA, Amin S (2018) Nanocarriers in advanced drug targeting: setting novel paradigm in cancer therapeutics. Artif Cells Nanomed Biotechnol 46(5):873–88410.1080/21691401.2017.1366333 ↗
69. Zhao N, You J, Zeng Z, Li C, Zu Y (2013) An ultra pH-sensitive and aptamer-equipped nanoscale drug-delivery system for selective killing of tumor cells. Small 9(20):3477–348410.1002/smll.201202694 ↗
70. Fire A, Xu S, Montgomery MK, Kostas SA, Driver SE, Mello CC (1998) Potent and specific genetic interference by double-stranded RNA in Caenorhabditis elegans. Nature 391(6669):806–1110.1038/35888 ↗
71. Baker M (2010) RNA interference: from tools to therapies. Nature 464(7292):122510.1038/4641225a ↗
72. Milhavet O, Gary DS, Mattson MP (2003) RNA interference in biology and medicine. Pharmacol Rev 55(4):629–64810.1124/pr.55.4.1 ↗
73. Wall NR, Shi Y (2003) Small RNA: can RNA interference be exploited for therapy? The Lancet 362(9393):1401–140310.1016/S0140-6736(03)14637-5 ↗
74. Hannon GJ, Rossi JJ (2004) Unlocking the potential of the human genome with RNA interference. Nature 431(7006):371–37810.1038/nature02870 ↗
75. Braun GB, Pallaoro A, Wu G, Missirlis D, Zasadzinski JA, Tirrell M et al (2009) Laser-activated gene silencing via gold nanoshell− siRNA conjugates. ACS Nano 3(7):2007–201510.1021/nn900469q ↗
76. Giljohann DA, Seferos DS, Prigodich AE, Patel PC, Mirkin CA (2009) Gene regulation with polyvalent siRNA− nanoparticle conjugates. J Am Chem Soc 131(6):2072–207310.1021/ja808719p ↗
77. Whitehead KA, Langer R, Anderson DG (2009) Knocking down barriers: advances in siRNA delivery. Nat Rev Drug Discovery 8(2):129–13810.1038/nrd2742 ↗
78. Lee J-S, Green JJ, Love KT, Sunshine J, Langer R, Anderson DG (2009) Gold, poly (β-amino ester) nanoparticles for small interfering RNA delivery. Nano Lett 9(6):2402–240610.1021/nl9009793 ↗
79. Lellouche E, Israel L, Bechor M, Attal S, Kurlander E, Asher V et al (2015) MagRET nanoparticles: an iron oxide nanocomposite platform for gene silencing from microRNAs to long noncoding RNAs. Bioconjug Chem 26(8):1692–170110.1021/acs.bioconjchem.5b00276 ↗
80. Castillo B, Bromberg L, Lopez X, Badillo V, González Feliciano JA, González CI et al. (2012) Intracellular delivery of siRNA by polycationic superparamagnetic nanoparticles. J Drug Del 201210.1155/2012/218940 ↗
81. Beg S, Almalki WH, Khatoon F, Alharbi KS, Alghamdi S, Akhter MH et al (2021) Lipid/polymer-based nanocomplexes in nucleic acid delivery as cancer vaccines. Drug Discovery Today 26(8):1891–190310.1016/j.drudis.2021.02.013 ↗
82. Li J, Ren H, Zhang Y (2022) Metal-based nano-vaccines for cancer immunotherapy. Coord Chem Rev 455:21434510.1016/j.ccr.2021.214345 ↗
83. Wen R, Umeano AC, Kou Y, Xu J, Farooqi AA (2019) Nanoparticle systems for cancer vaccine. Nanomedicine 14(5):627–64810.2217/nnm-2018-0147 ↗
84. Tornesello AL, Tagliamonte M, Tornesello ML, Buonaguro FM, Buonaguro L (2020) Nanoparticles to improve the efficacy of peptide-based cancer vaccines. Cancers 12(4):104910.3390/cancers12041049 ↗
85. Firdaus FZ, Skwarczynski M, Toth I (2022) Developments in vaccine adjuvants. Vaccine Design: Methods and Protocols, Resources for Vaccine Development 3:145–7810.1007/978-1-0716-1892-9_8 ↗
86. Evans ER, Bugga P, Asthana V, Drezek R (2018) Metallic nanoparticles for cancer immunotherapy. Mater Today 21(6):673–68510.1016/j.mattod.2017.11.022 ↗
87. Haume K, Rosa S, Grellet S, Śmiałek MA, Butterworth KT, Solov’yov AV et al (2016) Gold nanoparticles for cancer radiotherapy: a review. Cancer Nanotechnol 7:1–2010.1186/s12645-016-0021-x ↗
88. Haque M, Shakil MS, Mahmud KM (2023) The promise of nanoparticles-based radiotherapy in cancer treatment. Cancers 15(6):189210.3390/cancers15061892 ↗
89. Chang MY, Shiau AL, Chen YH, Chang CJ, Chen HHW, Wu CL (2008) Increased apoptotic potential and dose-enhancing effect of gold nanoparticles in combination with single-dose clinical electron beams on tumor-bearing mice. Cancer Sci 99(7):1479–148410.1111/j.1349-7006.2008.00827.x ↗
90. Niculescu A-G, Grumezescu AM (2021) Photodynamic therapy—an up-to-date review. Appl Sci 11(8):362610.3390/app11083626 ↗
91. Sharker SM (2021) Nanoparticle for photoresponsive minimal-invasive cancer therapy. Cancer Nanother 2:201–21610.1007/978-3-030-76263-6_8 ↗
92. Yang W, Liang H, Ma S, Wang D, Huang J (2019) Gold nanoparticle based photothermal therapy: development and application for effective cancer treatment. Sustain Mater Technol 22:e00109
93. Rimza T, Singh S, Kumar P (2022) Two-dimensional nanomaterials for cancer application. Elsevier, Biosensor Based Advanced Cancer Diagnostics, pp 321–331
94. Szunerits S, Boukherroub R (2018) Near-infrared photothermal heating with gold nanostructures10.1016/B978-0-12-409547-2.13228-7 ↗
95. Kang MS, Lee SY, Kim KS, Han D-W (2020) State of the art biocompatible gold nanoparticles for cancer theragnosis. Pharmaceutics 12(8):70110.3390/pharmaceutics12080701 ↗
96. Pivetta TP, Botteon CEA, Ribeiro PA, Marcato PD, Raposo M (2021) Nanoparticle systems for cancer phototherapy: an overview. Nanomaterials [Internet] 11(11)10.3390/nano11113132 ↗
97. Pallavi P, Girigoswami A, Girigoswami K, Hansda S, Ghosh R (2022) Photodynamic therapy in cancer. In: Chakraborti S (ed) Handbook of Oxidative Stress in Cancer: Therapeutic Aspects. Springer Nature Singapore, Singapore, pp 1285–130810.1007/978-981-16-5422-0_232 ↗
98. Dhar S, Daniel WL, Giljohann DA, Mirkin CA, Lippard SJ (2009) Polyvalent oligonucleotide gold nanoparticle conjugates as delivery vehicles for platinum (IV) warheads. J Am Chem Soc 131(41):14652–1465310.1021/ja9071282 ↗
99. Brown SD, Nativo P, Smith J-A, Stirling D, Edwards PR, Venugopal B et al (2010) Gold nanoparticles for the improved anticancer drug delivery of the active component of oxaliplatin. J Am Chem Soc 132(13):4678–468410.1021/ja908117a ↗
100. Hackenberg S, Scherzed A, Harnisch W, Froelich K, Ginzkey C, Koehler C et al (2012) Antitumor activity of photo-stimulated zinc oxide nanoparticles combined with paclitaxel or cisplatin in HNSCC cell lines. J Photochem Photobiol, B 114:87–9310.1016/j.jphotobiol.2012.05.014 ↗